Lol ozempic….because only fat people exist in US /s
ShortGuitar7207 on
It must be their fattest market although that could change when most of them are out of a job and can no longer afford food.
Glass-News-9184 on
It sounds like an ill-timed ultimatum.
Thready_C on
Just don’t let them, just tell them no, you can’t move
CRE178 on
Doesn’t say what an exodus means. If they mean putting up a manufacturing hub in the US so they don’t have to pay those tariffs, then whatever. If they think they can take off entirely and take the fruits of research subsidized with our public funds (their patents) with them, then I’m inclined to say that, seeing as we’re re-imagining the world order anyway, that’s got to be a hard no.
NeilDeCrash on
This was to be expected considering the weak response from the EU.
Every big producer, not just pharma, will just ditch the EU and start producing in the USA and then sell to Europe without paying any tariffs. EU will lose a lot of jobs if they don’t react properly.
Jasonstackhouse111 on
This is why the industry should have remained in the public sector.
sparksAndFizzles on
We need to impose counter-tariffs on US-based production re-exporting into the EU. If we don’t respond directly like that, we’re just sitting there while they rig the system against us.
Pharma and biopharma aren’t going to jump ship over this in any kind of a rush. They’ve invested billions upon billions in Europe over a very long time scale, have major R&D infrastructure, and rely on deeply embedded supply chains and highly specialist workforces. A lot of them are fully European—GSK, Sanofi, AstraZeneca, Novartis, Roche, Novo Nordisk. They like many others of US origin are true multinationals — take the Pfizer Covid vaccine for example, it was built on German biotech. BioNTech developed the core mRNA technology, Pfizer scaled it. That’s the reality—these systems are globally interconnected, highly complex and Europe is at the heart of them.
Pulling out would mean walking away from all of that—university R&D networks, specialist startups, scientific and engineering expertise, regulatory relationships, workforces they can’t replicate elsewhere. And for what?
The US is now highly politically unstable, the regulatory environment is a moving target and totally politicised, and there’s a level of open corruption that would be considered absolutely outrageous anywhere else. Politicians openly expect businesses to align with their political agendas—and to pay for access through huge donations. If you want a licence, you’re expected to play ball. If you want regulatory certainty, you’d better cough up. That’s not a functioning democracy—it’s a pay-to-play mess that’s increasingly not resembling a functioning, developed country, which is an absolutely shocking state of affairs.
They’d be leaving behind stability and scale for chaos. It wouldn’t just be costly—it would be utterly idiotic, very short term thinking.
cromethus on
Yeah? And how long does it take to stand up a new pharmaceutical factory? To train new workers? To get regulators to certify its products?
Stonkasaurus1 on
As with all tariffed items, by the time the facilities are built, and operating, the Trump administration will be gone. Why would people build factories over the next 5 years at the cost of billions of dollars when America needs the products and will pay for them regardless. Even if sales declined a bit, the net loss by moving will never be recovered and soon after a company moves, why wouldn’t the EU or anywhere else make the same demands.
Zoey_0110 on
The industry trade lobby the European Federation of Pharmaceutical Industries and Associations (EFPIA) statement titled “Pharma CEOs alert president von der Leyen to risk of exodus to the US,” said that “unless Europe delivers rapid, radical policy change then pharmaceutical research, development and manufacturing is increasingly likely to be directed towards the US”.
jacksawild on
Why would you “exodus” to an inflationary hellhole.
It wont happen. USA is done.
EU-National on
Fat m
HT_for_sheriff on
They could be commandeered, worst case scenario
Artaste-7989 on
If anyone thinks that companies like pharmaceuticals are going to flee like cockroaches, having to establish themselves in the US, with all that that entails, they should give it some thought.
sant2060 on
Good bye and good luck!
Let us know how it went.
cyaniod on
Okay so we do reciprocal tarrifs and equalise the costs
Icy-Atmosphere-1546 on
Under privatization companies have no allegiance to the greater good or a nation state.
cyaniod on
All these fuckers already have multiple plants in America. The European ones are supposedly to serve the EU market. So why the panick.
This feels like a stick up. A disgusting one at that.
FantasyFrikadel on
Why does the US need drug firms? When they have Chlorine?
Away-Dog1064 on
Takes years and years to start manufacturing there, good luck.
Sounds more like ‘never waste a good crisis’ to me.
hydrOHxide on
And what do they intend to do their, when scientists are headed the other way? Have an MBA develop a cure for pancreatic cancer?
futacios666 on
Insulin prices goes brrrrr in US
greenpowerman99 on
Wait until EU suspends US drug patents in Europe.
BioDriver on
He announced pharmaceutical tariffs last night. This is not a warning, it’s a promise
flyingdutchmnn on
Considering these tariffs will be gone soon, this is a load of shit
joosteto on
All while Trump is slashing biomedical research.
So the EU drug firms want to do the research in the EU (payed by EU), and make the profits in the US?
Snottygreenboy on
How will the pharma companies make money in the US if the Americans are impoverished and they also cut Medicare and Medicaid? Won’t they be biting their nose to spite their faces? And on top of that there’s an exodus of scientists and researchers fleeing the US and coming to the EU. This makes no sense to me
cyaniod on
So this feels like stick up. But there are only two ways to play this.
Option one is to bribe these fuckers with more incentives to stay which I sincerely hope the EU don’t go down that road not least because there has been enough corporate welfare thank you very much and these incentives like taxes have a habit of becoming premenant.
The other is to reciprocate tarrifs to equalise the transatlantic costs. This would then allow you to at least collect the tarrifs and use that money to help Europeans with their medication bills. Should you so choose. I’d rather help the common man out rather that filling the coffers of big business.
EU needs to understand the only way this ends is if Trump backs down I know some will say that won’t happen but things are gonna get real bad real fast in the US. The pressure on trump will be immense. We need to add to that.
Yes we will feel pain also but that will be inevitable the momonet trump inacts his tarrifs not least because input costs go up accross the board and they will pass that on to us here in Europe regardless.
We also have a moral duty to respond and a reputational one. Canada are getting praise for how they are standing up to trump they look strong and surefooted and they share a border with that nut house.
We need to follow their lead.
Mirar on
I’m sorry? Exodus *to* the US, or exodus *from* the US?
jaguarsadface on
Danish made Ozempic is the big one that the US depend on
PlanktonOk4560 on
Considering how long that it takes Nico to build factories in Denmark, Americans will be paying a heft price for ozempic and wegowy
leginfr on
Oh come on. It will take years for the pharmaceutical companies to build new facilities.
Ok_Photo_865 on
Changing the laws regarding knockoffs might just be what the Donald needs.
ChatamKay on
Explain this to me. Don’t just a many people in the EU need drugs as people in the USA? Why would tariffs in EU drug makers affect them. America’s can just pay more.
Helmidoric_of_York on
Inadvertently, he may have just done Puerto Rico a huge solid. We’ll have to wait and see…
PoGoCan on
I absolutely hate CEOs for falling in line with the current American kleptocratic demands
Hekke1969 on
How would any sane pharma company consider moving to the US as things are right now? – Their lunatic leader may change his idiotic demands next week ffs
Hikashuri on
EU can easily counter that by telling them if they do that, they will face up to 200% tariffs when exporting to the EU, which would effectively kill those companies as most of their overpriced products are subsidized by governments, which means easy and passive income.
39 commenti
Lol ozempic….because only fat people exist in US /s
It must be their fattest market although that could change when most of them are out of a job and can no longer afford food.
It sounds like an ill-timed ultimatum.
Just don’t let them, just tell them no, you can’t move
Doesn’t say what an exodus means. If they mean putting up a manufacturing hub in the US so they don’t have to pay those tariffs, then whatever. If they think they can take off entirely and take the fruits of research subsidized with our public funds (their patents) with them, then I’m inclined to say that, seeing as we’re re-imagining the world order anyway, that’s got to be a hard no.
This was to be expected considering the weak response from the EU.
Every big producer, not just pharma, will just ditch the EU and start producing in the USA and then sell to Europe without paying any tariffs. EU will lose a lot of jobs if they don’t react properly.
This is why the industry should have remained in the public sector.
We need to impose counter-tariffs on US-based production re-exporting into the EU. If we don’t respond directly like that, we’re just sitting there while they rig the system against us.
Pharma and biopharma aren’t going to jump ship over this in any kind of a rush. They’ve invested billions upon billions in Europe over a very long time scale, have major R&D infrastructure, and rely on deeply embedded supply chains and highly specialist workforces. A lot of them are fully European—GSK, Sanofi, AstraZeneca, Novartis, Roche, Novo Nordisk. They like many others of US origin are true multinationals — take the Pfizer Covid vaccine for example, it was built on German biotech. BioNTech developed the core mRNA technology, Pfizer scaled it. That’s the reality—these systems are globally interconnected, highly complex and Europe is at the heart of them.
Pulling out would mean walking away from all of that—university R&D networks, specialist startups, scientific and engineering expertise, regulatory relationships, workforces they can’t replicate elsewhere. And for what?
The US is now highly politically unstable, the regulatory environment is a moving target and totally politicised, and there’s a level of open corruption that would be considered absolutely outrageous anywhere else. Politicians openly expect businesses to align with their political agendas—and to pay for access through huge donations. If you want a licence, you’re expected to play ball. If you want regulatory certainty, you’d better cough up. That’s not a functioning democracy—it’s a pay-to-play mess that’s increasingly not resembling a functioning, developed country, which is an absolutely shocking state of affairs.
They’d be leaving behind stability and scale for chaos. It wouldn’t just be costly—it would be utterly idiotic, very short term thinking.
Yeah? And how long does it take to stand up a new pharmaceutical factory? To train new workers? To get regulators to certify its products?
As with all tariffed items, by the time the facilities are built, and operating, the Trump administration will be gone. Why would people build factories over the next 5 years at the cost of billions of dollars when America needs the products and will pay for them regardless. Even if sales declined a bit, the net loss by moving will never be recovered and soon after a company moves, why wouldn’t the EU or anywhere else make the same demands.
The industry trade lobby the European Federation of Pharmaceutical Industries and Associations (EFPIA) statement titled “Pharma CEOs alert president von der Leyen to risk of exodus to the US,” said that “unless Europe delivers rapid, radical policy change then pharmaceutical research, development and manufacturing is increasingly likely to be directed towards the US”.
Why would you “exodus” to an inflationary hellhole.
It wont happen. USA is done.
Fat m
They could be commandeered, worst case scenario
If anyone thinks that companies like pharmaceuticals are going to flee like cockroaches, having to establish themselves in the US, with all that that entails, they should give it some thought.
Good bye and good luck!
Let us know how it went.
Okay so we do reciprocal tarrifs and equalise the costs
Under privatization companies have no allegiance to the greater good or a nation state.
All these fuckers already have multiple plants in America. The European ones are supposedly to serve the EU market. So why the panick.
This feels like a stick up. A disgusting one at that.
Why does the US need drug firms? When they have Chlorine?
Takes years and years to start manufacturing there, good luck.
Sounds more like ‘never waste a good crisis’ to me.
And what do they intend to do their, when scientists are headed the other way? Have an MBA develop a cure for pancreatic cancer?
Insulin prices goes brrrrr in US
Wait until EU suspends US drug patents in Europe.
He announced pharmaceutical tariffs last night. This is not a warning, it’s a promise
Considering these tariffs will be gone soon, this is a load of shit
All while Trump is slashing biomedical research.
So the EU drug firms want to do the research in the EU (payed by EU), and make the profits in the US?
How will the pharma companies make money in the US if the Americans are impoverished and they also cut Medicare and Medicaid? Won’t they be biting their nose to spite their faces? And on top of that there’s an exodus of scientists and researchers fleeing the US and coming to the EU. This makes no sense to me
So this feels like stick up. But there are only two ways to play this.
Option one is to bribe these fuckers with more incentives to stay which I sincerely hope the EU don’t go down that road not least because there has been enough corporate welfare thank you very much and these incentives like taxes have a habit of becoming premenant.
The other is to reciprocate tarrifs to equalise the transatlantic costs. This would then allow you to at least collect the tarrifs and use that money to help Europeans with their medication bills. Should you so choose. I’d rather help the common man out rather that filling the coffers of big business.
EU needs to understand the only way this ends is if Trump backs down I know some will say that won’t happen but things are gonna get real bad real fast in the US. The pressure on trump will be immense. We need to add to that.
Yes we will feel pain also but that will be inevitable the momonet trump inacts his tarrifs not least because input costs go up accross the board and they will pass that on to us here in Europe regardless.
We also have a moral duty to respond and a reputational one. Canada are getting praise for how they are standing up to trump they look strong and surefooted and they share a border with that nut house.
We need to follow their lead.
I’m sorry? Exodus *to* the US, or exodus *from* the US?
Danish made Ozempic is the big one that the US depend on
Considering how long that it takes Nico to build factories in Denmark, Americans will be paying a heft price for ozempic and wegowy
Oh come on. It will take years for the pharmaceutical companies to build new facilities.
Changing the laws regarding knockoffs might just be what the Donald needs.
Explain this to me. Don’t just a many people in the EU need drugs as people in the USA? Why would tariffs in EU drug makers affect them. America’s can just pay more.
Inadvertently, he may have just done Puerto Rico a huge solid. We’ll have to wait and see…
I absolutely hate CEOs for falling in line with the current American kleptocratic demands
How would any sane pharma company consider moving to the US as things are right now? – Their lunatic leader may change his idiotic demands next week ffs
EU can easily counter that by telling them if they do that, they will face up to 200% tariffs when exporting to the EU, which would effectively kill those companies as most of their overpriced products are subsidized by governments, which means easy and passive income.